Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Most of the rest of this information is about hepatocellular carcinoma and will be referred to as liver cancer. About 10% to 20% of liver cancers start in the cells that line the small bile ducts ...

In this case report, we describe mammographic, sonographic and MRI findings, in addition to surgical and histopathologic findings, in a patient with PBNHL. In particular, the diffusion-weighted ...

Its findings, which are the earliest evidence of a complex adhesive in Europe, ... Feb. 13, 2024 — Babies playfully tease others as young as eight months of age. Since language is not required ...

Feb. 11, 2025 — A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are ... 'Junk' RNA Segments Play ...

The nation must lose its tight focus on individual disciplines if it is to keep pace with the evolving requirements of scientific enquiry.